- Home
- ANTX vs DALN Comparison
ANTX vs DALN Comparison
Compare ANTX & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- DALN
- Stock Information
- Founded
- ANTX 2017
- DALN 1954
- Country
- ANTX United States
- DALN United States
- Employees
- ANTX N/A
- DALN 534
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- DALN Newspapers/Magazines
- Sector
- ANTX Health Care
- DALN Consumer Discretionary
- Exchange
- ANTX Nasdaq
- DALN Nasdaq
- Market Cap
- ANTX 37.6M
- DALN 38.1M
- IPO Year
- ANTX 2022
- DALN 2008
- Fundamental
- Price
- ANTX $1.41
- DALN $7.11
- Analyst Decision
- ANTX Hold
- DALN
- Analyst Count
- ANTX 5
- DALN 0
- Target Price
- ANTX $3.50
- DALN N/A
- AVG Volume (30 Days)
- ANTX 168.1K
- DALN 39.3K
- Earning Date
- ANTX 03-27-2025
- DALN 05-13-2025
- Dividend Yield
- ANTX N/A
- DALN N/A
- EPS Growth
- ANTX N/A
- DALN N/A
- EPS
- ANTX N/A
- DALN N/A
- Revenue
- ANTX N/A
- DALN $128,286,000.00
- Revenue This Year
- ANTX N/A
- DALN N/A
- Revenue Next Year
- ANTX N/A
- DALN N/A
- P/E Ratio
- ANTX N/A
- DALN N/A
- Revenue Growth
- ANTX N/A
- DALN N/A
- 52 Week Low
- ANTX $0.87
- DALN $2.98
- 52 Week High
- ANTX $3.88
- DALN $7.86
- Technical
- Relative Strength Index (RSI)
- ANTX 72.16
- DALN 63.46
- Support Level
- ANTX $1.09
- DALN $6.00
- Resistance Level
- ANTX $1.39
- DALN $6.65
- Average True Range (ATR)
- ANTX 0.06
- DALN 0.47
- MACD
- ANTX 0.03
- DALN 0.09
- Stochastic Oscillator
- ANTX 94.20
- DALN 68.78
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.